These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 34070746)
1. Opposed Interplay between IDH1 Mutations and the WNT/β-Catenin Pathway: Added Information for Glioma Classification. Vallée A; Lecarpentier Y; Vallée JN Biomedicines; 2021 May; 9(6):. PubMed ID: 34070746 [TBL] [Abstract][Full Text] [Related]
2. Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas. Vallée A; Guillevin R; Vallée JN Rev Neurosci; 2018 Jan; 29(1):71-91. PubMed ID: 28822229 [TBL] [Abstract][Full Text] [Related]
3. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling. Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959 [TBL] [Abstract][Full Text] [Related]
4. The Key Role of the WNT/β-Catenin Pathway in Metabolic Reprogramming in Cancers under Normoxic Conditions. Vallée A; Lecarpentier Y; Vallée JN Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771718 [TBL] [Abstract][Full Text] [Related]
5. Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells. Fan D; Yue Q; Chen J; Wang C; Yu R; Jin Z; Yin S; Wang Q; Chen L; Liao X; Peng C; Zhang J; Cao Z; Mao Y; Huang R; Chen L; Li C Oncoimmunology; 2021 Jun; 10(1):1932061. PubMed ID: 34123575 [TBL] [Abstract][Full Text] [Related]
6. Autocrine BMP4 Signaling Enhances Tumor Aggressiveness via Promoting Wnt/β-Catenin Signaling in IDH1-mutant Gliomas. Zhou Y; Liu Y; Zhang J; Yu D; Li A; Song H; Zhang W; Davis D; Gilbert MR; Liu F; Yang C Transl Oncol; 2020 Feb; 13(2):125-134. PubMed ID: 31865175 [TBL] [Abstract][Full Text] [Related]
7. (Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway. Kouchi M; Shibayama Y; Ogawa D; Miyake K; Nishiyama A; Tamiya T J Neurosurg; 2017 Oct; 127(4):819-828. PubMed ID: 28059652 [TBL] [Abstract][Full Text] [Related]
8. Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas. Vallée A; Lecarpentier Y; Guillevin R; Vallée JN Neurosci Bull; 2018 Jun; 34(3):573-588. PubMed ID: 29582250 [TBL] [Abstract][Full Text] [Related]
9. Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma. Agnihotri S; Aldape KD; Zadeh G Neurosurg Focus; 2014 Dec; 37(6):E13. PubMed ID: 25434382 [TBL] [Abstract][Full Text] [Related]
10. Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma. Vallée A; Lecarpentier Y; Guillevin R; Vallée JN Front Physiol; 2017; 8():352. PubMed ID: 28620312 [TBL] [Abstract][Full Text] [Related]
11. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis. Vallée A; Lecarpentier Y Front Immunol; 2018; 9():745. PubMed ID: 29706964 [TBL] [Abstract][Full Text] [Related]
12. Malignant gliomas induce and exploit astrocytic mesenchymal-like transition by activating canonical Wnt/β-catenin signaling. Lu P; Wang Y; Liu X; Wang H; Zhang X; Wang K; Wang Q; Hu R Med Oncol; 2016 Jul; 33(7):66. PubMed ID: 27236327 [TBL] [Abstract][Full Text] [Related]
13. The expressions of Wnt/β-catenin pathway-related components in brainstem gliomas. Wu W; Tian Y; Wan H; Song Y; Li J; Zhang L Can J Neurol Sci; 2013 May; 40(3):355-60. PubMed ID: 23603171 [TBL] [Abstract][Full Text] [Related]
14. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion. Náger M; Santacana M; Bhardwaj D; Valls J; Ferrer I; Nogués P; Cantí C; Herreros J Cell Cycle; 2015; 14(22):3644-55. PubMed ID: 26654598 [TBL] [Abstract][Full Text] [Related]
15. IDH1 mutation diminishes aggressive phenotype in glioma stem cells. Yao Q; Cai G; Yu Q; Shen J; Gu Z; Chen J; Shi W; Shi J Int J Oncol; 2018 Jan; 52(1):270-278. PubMed ID: 29115585 [TBL] [Abstract][Full Text] [Related]
16. Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas. Götze S; Wolter M; Reifenberger G; Müller O; Sievers S Int J Cancer; 2010 Jun; 126(11):2584-93. PubMed ID: 19847810 [TBL] [Abstract][Full Text] [Related]
18. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha. Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factors modulate the stemness and malignancy of colon cancer cells by playing opposite roles in canonical Wnt signaling. Santoyo-Ramos P; Likhatcheva M; García-Zepeda EA; Castañeda-Patlán MC; Robles-Flores M PLoS One; 2014; 9(11):e112580. PubMed ID: 25396735 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Pu P; Zhang Z; Kang C; Jiang R; Jia Z; Wang G; Jiang H Cancer Gene Ther; 2009 Apr; 16(4):351-61. PubMed ID: 18949017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]